Viewing Study NCT03446261


Ignite Creation Date: 2025-12-24 @ 11:55 AM
Ignite Modification Date: 2026-01-06 @ 5:35 AM
Study NCT ID: NCT03446261
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2018-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
Sponsor: Yuhan Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module